Global Longevity and Anti-senescence Therapy Market Growth (Status and Outlook) 2022-2028

January 2021 | 85 pages | ID: G78A4873D4BEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Longevity and Anti-senescence Therapy will have significant change from previous year. According to our (LP Information) latest study, the global Longevity and Anti-senescence Therapy market size is USD million in 2022 from USD 311.4 million in 2021, with a change of % between 2021 and 2022. The global Longevity and Anti-senescence Therapy market size will reach USD 547.8 million in 2028, growing at a CAGR of 8.4% over the analysis period.

The United States Longevity and Anti-senescence Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Longevity and Anti-senescence Therapy market, reaching US$ million by the year 2028. As for the Europe Longevity and Anti-senescence Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Longevity and Anti-senescence Therapy players cover CohBar, TA Sciences, Unity Biotechnology, and AgeX Therapeutics?Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Longevity and Anti-senescence Therapy market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Hemolytic Drug Therapy
• Gene Therapy
• Immunotherapy
• Other Stem Cell Therapies

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Hospital
• Medical Service Institution
• Drug and Device Sales

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• CohBar
• TA Sciences
• Unity Biotechnology
• AgeX Therapeutics?Inc
• PowerVision Inc.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Longevity and Anti-senescence Therapy Market Size 2017-2028
  2.1.2 Longevity and Anti-senescence Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Longevity and Anti-senescence Therapy Segment by Type
  2.2.1 Hemolytic Drug Therapy
  2.2.2 Gene Therapy
  2.2.3 Immunotherapy
  2.2.4 Other Stem Cell Therapies
2.3 Longevity and Anti-senescence Therapy Market Size by Type
  2.3.1 Longevity and Anti-senescence Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Longevity and Anti-senescence Therapy Market Size Market Share by Type (2017-2022)
2.4 Longevity and Anti-senescence Therapy Segment by Application
  2.4.1 Hospital
  2.4.2 Medical Service Institution
  2.4.3 Drug and Device Sales
2.5 Longevity and Anti-senescence Therapy Market Size by Application
  2.5.1 Longevity and Anti-senescence Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
  2.5.2 Global Longevity and Anti-senescence Therapy Market Size Market Share by Application (2017-2022)

3 LONGEVITY AND ANTI-SENESCENCE THERAPY MARKET SIZE BY PLAYER

3.1 Longevity and Anti-senescence Therapy Market Size Market Share by Players
  3.1.1 Global Longevity and Anti-senescence Therapy Revenue by Players (2020-2022)
  3.1.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Longevity and Anti-senescence Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 LONGEVITY AND ANTI-SENESCENCE THERAPY BY REGIONS

4.1 Longevity and Anti-senescence Therapy Market Size by Regions (2017-2022)
4.2 Americas Longevity and Anti-senescence Therapy Market Size Growth (2017-2022)
4.3 APAC Longevity and Anti-senescence Therapy Market Size Growth (2017-2022)
4.4 Europe Longevity and Anti-senescence Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Longevity and Anti-senescence Therapy Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Longevity and Anti-senescence Therapy Market Size by Country (2017-2022)
5.2 Americas Longevity and Anti-senescence Therapy Market Size by Type (2017-2022)
5.3 Americas Longevity and Anti-senescence Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Longevity and Anti-senescence Therapy Market Size by Region (2017-2022)
6.2 APAC Longevity and Anti-senescence Therapy Market Size by Type (2017-2022)
6.3 APAC Longevity and Anti-senescence Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Longevity and Anti-senescence Therapy by Country (2017-2022)
7.2 Europe Longevity and Anti-senescence Therapy Market Size by Type (2017-2022)
7.3 Europe Longevity and Anti-senescence Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Longevity and Anti-senescence Therapy by Region (2017-2022)
8.2 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL LONGEVITY AND ANTI-SENESCENCE THERAPY MARKET FORECAST

10.1 Global Longevity and Anti-senescence Therapy Forecast by Regions (2023-2028)
  10.1.1 Global Longevity and Anti-senescence Therapy Forecast by Regions (2023-2028)
  10.1.2 Americas Longevity and Anti-senescence Therapy Forecast
  10.1.3 APAC Longevity and Anti-senescence Therapy Forecast
  10.1.4 Europe Longevity and Anti-senescence Therapy Forecast
  10.1.5 Middle East & Africa Longevity and Anti-senescence Therapy Forecast
10.2 Americas Longevity and Anti-senescence Therapy Forecast by Country (2023-2028)
  10.2.1 United States Longevity and Anti-senescence Therapy Market Forecast
  10.2.2 Canada Longevity and Anti-senescence Therapy Market Forecast
  10.2.3 Mexico Longevity and Anti-senescence Therapy Market Forecast
  10.2.4 Brazil Longevity and Anti-senescence Therapy Market Forecast
10.3 APAC Longevity and Anti-senescence Therapy Forecast by Region (2023-2028)
  10.3.1 China Longevity and Anti-senescence Therapy Market Forecast
  10.3.2 Japan Longevity and Anti-senescence Therapy Market Forecast
  10.3.3 Korea Longevity and Anti-senescence Therapy Market Forecast
  10.3.4 Southeast Asia Longevity and Anti-senescence Therapy Market Forecast
  10.3.5 India Longevity and Anti-senescence Therapy Market Forecast
  10.3.6 Australia Longevity and Anti-senescence Therapy Market Forecast
10.4 Europe Longevity and Anti-senescence Therapy Forecast by Country (2023-2028)
  10.4.1 Germany Longevity and Anti-senescence Therapy Market Forecast
  10.4.2 France Longevity and Anti-senescence Therapy Market Forecast
  10.4.3 UK Longevity and Anti-senescence Therapy Market Forecast
  10.4.4 Italy Longevity and Anti-senescence Therapy Market Forecast
  10.4.5 Russia Longevity and Anti-senescence Therapy Market Forecast
10.5 Middle East & Africa Longevity and Anti-senescence Therapy Forecast by Region (2023-2028)
  10.5.1 Egypt Longevity and Anti-senescence Therapy Market Forecast
  10.5.2 South Africa Longevity and Anti-senescence Therapy Market Forecast
  10.5.3 Israel Longevity and Anti-senescence Therapy Market Forecast
  10.5.4 Turkey Longevity and Anti-senescence Therapy Market Forecast
  10.5.5 GCC Countries Longevity and Anti-senescence Therapy Market Forecast
10.6 Global Longevity and Anti-senescence Therapy Forecast by Type (2023-2028)
10.7 Global Longevity and Anti-senescence Therapy Forecast by Application (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 CohBar
  11.1.1 CohBar Company Information
  11.1.2 CohBar Longevity and Anti-senescence Therapy Product Offered
  11.1.3 CohBar Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 CohBar Main Business Overview
  11.1.5 CohBar Latest Developments
11.2 TA Sciences
  11.2.1 TA Sciences Company Information
  11.2.2 TA Sciences Longevity and Anti-senescence Therapy Product Offered
  11.2.3 TA Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 TA Sciences Main Business Overview
  11.2.5 TA Sciences Latest Developments
11.3 Unity Biotechnology
  11.3.1 Unity Biotechnology Company Information
  11.3.2 Unity Biotechnology Longevity and Anti-senescence Therapy Product Offered
  11.3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Unity Biotechnology Main Business Overview
  11.3.5 Unity Biotechnology Latest Developments
11.4 AgeX Therapeutics?Inc
  11.4.1 AgeX Therapeutics?Inc Company Information
  11.4.2 AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Product Offered
  11.4.3 AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 AgeX Therapeutics?Inc Main Business Overview
  11.4.5 AgeX Therapeutics?Inc Latest Developments
11.5 PowerVision Inc.
  11.5.1 PowerVision Inc. Company Information
  11.5.2 PowerVision Inc. Longevity and Anti-senescence Therapy Product Offered
  11.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 PowerVision Inc. Main Business Overview
  11.5.5 PowerVision Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Longevity and Anti-senescence Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Hemolytic Drug Therapy
Table 3. Major Players of Gene Therapy
Table 4. Major Players of Immunotherapy
Table 5. Major Players of Other Stem Cell Therapies
Table 6. Longevity and Anti-senescence Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Longevity and Anti-senescence Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Longevity and Anti-senescence Therapy Market Size Market Share by Type (2017-2022)
Table 9. Longevity and Anti-senescence Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Longevity and Anti-senescence Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Longevity and Anti-senescence Therapy Market Size Market Share by Application (2017-2022)
Table 12. Global Longevity and Anti-senescence Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Longevity and Anti-senescence Therapy Revenue Market Share by Player (2020-2022)
Table 14. Longevity and Anti-senescence Therapy Key Players Head office and Products Offered
Table 15. Longevity and Anti-senescence Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Longevity and Anti-senescence Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Longevity and Anti-senescence Therapy Market Size Market Share by Regions (2017-2022)
Table 20. Americas Longevity and Anti-senescence Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Longevity and Anti-senescence Therapy Market Size Market Share by Country (2017-2022)
Table 22. Americas Longevity and Anti-senescence Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Longevity and Anti-senescence Therapy Market Size Market Share by Type (2017-2022)
Table 24. Americas Longevity and Anti-senescence Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Longevity and Anti-senescence Therapy Market Size Market Share by Application (2017-2022)
Table 26. APAC Longevity and Anti-senescence Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Longevity and Anti-senescence Therapy Market Size Market Share by Region (2017-2022)
Table 28. APAC Longevity and Anti-senescence Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Longevity and Anti-senescence Therapy Market Size Market Share by Type (2017-2022)
Table 30. APAC Longevity and Anti-senescence Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Longevity and Anti-senescence Therapy Market Size Market Share by Application (2017-2022)
Table 32. Europe Longevity and Anti-senescence Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Longevity and Anti-senescence Therapy Market Size Market Share by Country (2017-2022)
Table 34. Europe Longevity and Anti-senescence Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Longevity and Anti-senescence Therapy Market Size Market Share by Type (2017-2022)
Table 36. Europe Longevity and Anti-senescence Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Longevity and Anti-senescence Therapy Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Longevity and Anti-senescence Therapy Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Longevity and Anti-senescence Therapy Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Longevity and Anti-senescence Therapy Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Longevity and Anti-senescence Therapy
Table 45. Key Market Challenges & Risks of Longevity and Anti-senescence Therapy
Table 46. Key Industry Trends of Longevity and Anti-senescence Therapy
Table 47. Global Longevity and Anti-senescence Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Longevity and Anti-senescence Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Longevity and Anti-senescence Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Longevity and Anti-senescence Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Longevity and Anti-senescence Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Longevity and Anti-senescence Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 53. CohBar Details, Company Type, Longevity and Anti-senescence Therapy Area Served and Its Competitors
Table 54. CohBar Longevity and Anti-senescence Therapy Product Offered
Table 55. CohBar Longevity and Anti-senescence Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. CohBar Main Business
Table 57. CohBar Latest Developments
Table 58. TA Sciences Details, Company Type, Longevity and Anti-senescence Therapy Area Served and Its Competitors
Table 59. TA Sciences Longevity and Anti-senescence Therapy Product Offered
Table 60. TA Sciences Main Business
Table 61. TA Sciences Longevity and Anti-senescence Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. TA Sciences Latest Developments
Table 63. Unity Biotechnology Details, Company Type, Longevity and Anti-senescence Therapy Area Served and Its Competitors
Table 64. Unity Biotechnology Longevity and Anti-senescence Therapy Product Offered
Table 65. Unity Biotechnology Main Business
Table 66. Unity Biotechnology Longevity and Anti-senescence Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Unity Biotechnology Latest Developments
Table 68. AgeX Therapeutics?Inc Details, Company Type, Longevity and Anti-senescence Therapy Area Served and Its Competitors
Table 69. AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Product Offered
Table 70. AgeX Therapeutics?Inc Main Business
Table 71. AgeX Therapeutics?Inc Longevity and Anti-senescence Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. AgeX Therapeutics?Inc Latest Developments
Table 73. PowerVision Inc. Details, Company Type, Longevity and Anti-senescence Therapy Area Served and Its Competitors
Table 74. PowerVision Inc. Longevity and Anti-senescence Therapy Product Offered
Table 75. PowerVision Inc. Main Business
Table 76. PowerVision Inc. Longevity and Anti-senescence Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. PowerVision Inc. Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Longevity and Anti-senescence Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Longevity and Anti-senescence Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Longevity and Anti-senescence Therapy Market Size Market Share by Type in 2021
Figure 7. Longevity and Anti-senescence Therapy in Hospital
Figure 8. Global Longevity and Anti-senescence Therapy Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Longevity and Anti-senescence Therapy in Medical Service Institution
Figure 10. Global Longevity and Anti-senescence Therapy Market: Medical Service Institution (2017-2022) & ($ Millions)
Figure 11. Longevity and Anti-senescence Therapy in Drug and Device Sales
Figure 12. Global Longevity and Anti-senescence Therapy Market: Drug and Device Sales (2017-2022) & ($ Millions)
Figure 13. Global Longevity and Anti-senescence Therapy Market Size Market Share by Application in 2021
Figure 14. Global Longevity and Anti-senescence Therapy Revenue Market Share by Player in 2021
Figure 15. Global Longevity and Anti-senescence Therapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Longevity and Anti-senescence Therapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Longevity and Anti-senescence Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Longevity and Anti-senescence Therapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Longevity and Anti-senescence Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Longevity and Anti-senescence Therapy Value Market Share by Country in 2021
Figure 21. Americas Longevity and Anti-senescence Therapy Consumption Market Share by Type in 2021
Figure 22. Americas Longevity and Anti-senescence Therapy Market Size Market Share by Application in 2021
Figure 23. United States Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Longevity and Anti-senescence Therapy Market Size Market Share by Region in 2021
Figure 28. APAC Longevity and Anti-senescence Therapy Market Size Market Share by Application in 2021
Figure 29. China Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Longevity and Anti-senescence Therapy Market Size Market Share by Country in 2021
Figure 36. Europe Longevity and Anti-senescence Therapy Market Size Market Share by Type in 2021
Figure 37. Europe Longevity and Anti-senescence Therapy Market Size Market Share by Application in 2021
Figure 38. Germany Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Longevity and Anti-senescence Therapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Longevity and Anti-senescence Therapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Longevity and Anti-senescence Therapy Market Size Market Share by Application in 2021
Figure 46. Egypt Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Longevity and Anti-senescence Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 59. China Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 63. India Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 66. France Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Longevity and Anti-senescence Therapy Market Size 2023-2028 ($ Millions)